Baropharm Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Public

  • Employees
  • 55

Employees

  • Stock Symbol
  • 0153R0

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $4.20
  • (As of Friday Closing)

Baropharm General Information

Description

BaroPharm Co operates a healthcare platform business based on IT technology that supports the efficiency of pharmaceutical ordering and management operations in pharmacies. Its key services consist of integrated pharmaceutical ordering, price and inventory comparison, payment and return notifications, and out-of-stock and restock alerts, along with functions such as pharmaceutical information search, education, community features, and management support.

Contact Information

Formerly Known As
Now FarmNet
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 77, Dongjak-daero
  • Dongjak-gu
  • Seoul
  • South Korea
+82
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 77, Dongjak-daero
  • Dongjak-gu
  • Seoul
  • South Korea
+82

Baropharm Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baropharm Stock Performance

As of 20-Nov-2026, Baropharm’s stock price is $4.20. Its current market cap is $50.3M with 12M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.20 $4.89 $4.07 - $12.94 $50.3M 12M 3.38M

Baropharm Financials Summary

As of 31-Dec-2025, Baropharm has a trailing 12-month revenue of $67.9M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
Revenue 67,949 67,949 33,347 8,872
Total Assets 22,096
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Baropharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baropharm‘s full profile, request access.

Request a free trial

Baropharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baropharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baropharm‘s full profile, request access.

Request a free trial

Baropharm Acquisitions (2)

Baropharm’s most recent deal was a Merger/Acquisition with CHD Pharmaceuticals. The deal was made on 01-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CHD Pharmaceuticals 01-May-2026 Merger/Acquisition Other Commercial Products
Brp Labs 01-Jan-2023 Merger/Acquisition Drug Discovery
To view Baropharm’s complete acquisitions history, request access »

Baropharm Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Brp Labs Incheon, South Korea 2009
CHD Pharmaceuticals Goyang-si, South Korea 2003

Baropharm FAQs

  • When was Baropharm founded?

    Baropharm was founded in 2019.

  • Where is Baropharm headquartered?

    Baropharm is headquartered in Seoul, South Korea.

  • What is the size of Baropharm?

    Baropharm has 55 total employees.

  • What industry is Baropharm in?

    Baropharm’s primary industry is Enterprise Systems (Healthcare).

  • Is Baropharm a private or public company?

    Baropharm is a Public company.

  • What is Baropharm’s stock symbol?

    The ticker symbol for Baropharm is 0153R0.

  • What is the current stock price of Baropharm?

    As of 20-Nov-2026 the stock price of Baropharm is $4.20.

  • What is the current market cap of Baropharm?

    The current market capitalization of Baropharm is $50.3M.

  • What is Baropharm’s current revenue?

    The trailing twelve month revenue for Baropharm is $67.9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process